This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%. Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. There are no easy answers to this key questi ...

Core Viewpoint - Century Aluminum reported quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.53 per share, representing a 47.17% earnings surprise [1] - The company posted revenues of $633.9 million for the quarter, missing the Zacks Consensus Estimate by 1.54%, but showing an increase from $489.5 million year-over-year [2] Financial Performance - The earnings report indicates a loss of $0.39 per share in the same quarter last year, highlighting a significant improvement in earnings [1] - Over the last four quarters, Century has surpassed consensus EPS estimates two times and topped revenue estimates twice [2] Stock Performance - Century shares have declined approximately 9.7% since the beginning of the year, compared to a 4.7% decline in the S&P 500 [3] - The current Zacks Rank for Century is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $660.1 million, and for the current fiscal year, it is $3.36 on revenues of $2.48 billion [7] - The Metal Products - Procurement and Fabrication industry is currently in the top 31% of Zacks industries, suggesting a favorable industry outlook [8]

Financial Performance - Alta Equipment reported a quarterly loss of $0.65 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.60, and compared to a loss of $0.38 per share a year ago, indicating a decline in performance [1] - The company posted revenues of $423 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 3.11%, and down from $441.6 million in the same quarter last year [2] - Over the last four quarters, Alta Equipment has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Stock Performance - Since the beginning of the year, Alta Equipment shares have lost approximately 27.1%, significantly underperforming the S&P 500, which declined by 4.7% [3] - The current Zacks Rank for Alta Equipment is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.30 on revenues of $482.42 million, and for the current fiscal year, it is -$1.39 on revenues of $1.89 billion [7] - The trend of estimate revisions for Alta Equipment is mixed, and future changes in estimates will be closely monitored following the recent earnings report [6][7] Industry Context - The Manufacturing - General Industrial industry, to which Alta Equipment belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, suggesting a challenging environment for the sector [8]

Company Performance - LegalZoom reported quarterly earnings of $0.13 per share, matching the Zacks Consensus Estimate, and an increase from $0.09 per share a year ago [1] - The company posted revenues of $183.11 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 3.74% and up from $174.21 million year-over-year [2] - LegalZoom has surpassed consensus EPS estimates three times over the last four quarters [1][2] Market Outlook - LegalZoom shares have declined approximately 3.2% since the beginning of the year, compared to a 4.7% decline in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $180.1 million, and for the current fiscal year, it is $0.66 on revenues of $710.65 million [7] Industry Context - The Industrial Services industry, to which LegalZoom belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of LegalZoom's stock may be influenced by the overall outlook for the industry [8]

Company Performance - Hamilton Insurance reported quarterly earnings of $0.47 per share, significantly exceeding the Zacks Consensus Estimate of $0.04 per share, but down from $1.38 per share a year ago, representing an earnings surprise of 1,075% [1] - The company posted revenues of $768.78 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 31.08%, compared to $658.65 million in the same quarter last year [2] - Over the last four quarters, Hamilton Insurance has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Outlook - The immediate price movement of Hamilton Insurance's stock will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.01 on revenues of $617.28 million, and for the current fiscal year, it is $2.66 on revenues of $2.48 billion [7] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Industry Context - The Insurance - Multi line industry, to which Hamilton Insurance belongs, is currently ranked in the top 31% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Emergent Biosolutions (EBS) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 44.90%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.35 per share when it actually produced earnings of $0.05, delivering a surprise of 114.29%.Over the last four ...

VERRA MOBILITY CORP (VRRM) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.45%. A quarter ago, it was expected that this company would post earnings of $0.30 per share when it actually produced earnings of $0.33, delivering a surprise of 10%.Over the last four quarters, the company ...

Biote Corp. (BTMD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this company would post earnings of $0.09 per share when it actually produced earnings of $0.10, delivering a surprise of 11.11%. There are no easy answers to this key quest ...

Core Viewpoint - Identiv, Inc. reported a quarterly loss of $0.21 per share, which was better than the Zacks Consensus Estimate of a loss of $0.24, indicating a 12.50% earnings surprise [1] Financial Performance - The company posted revenues of $5.27 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.38%, but down from $22.49 million year-over-year [2] - Over the last four quarters, Identiv has exceeded consensus EPS estimates three times and topped consensus revenue estimates three times as well [2] Stock Performance - Identiv shares have declined approximately 12.6% since the beginning of the year, compared to a decline of 4.7% for the S&P 500 [3] Future Outlook - The company's earnings outlook will be crucial for determining the stock's immediate price movement, with current consensus EPS estimates at -$0.26 for the coming quarter and -$0.97 for the current fiscal year [4][7] - The estimate revisions trend for Identiv is currently mixed, resulting in a Zacks Rank 3 (Hold), suggesting the shares are expected to perform in line with the market in the near future [6] Industry Context - The Computer - Peripheral Equipment industry, to which Identiv belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

分组1 - Mirum Pharmaceuticals reported a quarterly loss of $0.30 per share, better than the Zacks Consensus Estimate of a loss of $0.39, and improved from a loss of $0.54 per share a year ago, representing an earnings surprise of 23.08% [1] - The company posted revenues of $111.59 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 13.32%, and compared to year-ago revenues of $69.22 million [2] - Mirum Pharmaceuticals has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has lost about 0.9% since the beginning of the year, while the S&P 500 has declined by 4.7% [3] - The current consensus EPS estimate for the coming quarter is -$0.35 on revenues of $102.78 million, and for the current fiscal year, it is -$1.23 on revenues of $427.82 million [7] - The Medical - Biomedical and Genetics industry is currently in the top 35% of Zacks industries, indicating a favorable outlook for stocks within this sector [8]